Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Noll NTUS stock SEC Form 4 insiders trading
Austin has made over 6 trades of the Natus Medical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of NTUS stock worth $450,000 on 31 July 2019.
The largest trade he's ever made was exercising 38,875 units of Natus Medical Inc stock on 25 November 2015 worth over $515,871. On average, Austin trades about 4,829 units every 61 days since 2013. As of 31 July 2019 he still owns at least 105,193 units of Natus Medical Inc stock.
You can see the complete history of Mr. Noll stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Austin Noll biography
Austin F. Noll III serves as Executive Vice President and Chief Commercial Officer of the Company. Mr. Noll has been Executive Vice President and Chief Commercial Officer since January 2019. Mr. Noll joined Natus in August 2012 as the Vice President and General Manager, Neurology SBU. Prior to joining Natus, Mr. Noll served as the President and CEO of Simpirica Spine, a California-based start-up company that developed and commercialized a novel device for spinal stabilization from June 2009 to August 2012. Prior to joining Simpirica Spine, Mr. Noll served as the President and CEO of NeoGuide Systems, a medical robotics company acquired by Intuitive Surgical, from November 2006 to May 2009. Prior to joining NeoGuide Systems, Mr. Noll held numerous management positions at Medtronic over 13-year period, where he served as the Vice President and General Manager of the Powered Surgical Solutions and the Neurosurgery businesses from April 2004 to June 2005. Mr. Noll received a bachelor's degree in business administration from Miami University and a master's of business administration from the University of Michigan.
What is the salary of Austin Noll?
As the Executive Vice President and Chief Commercial Officer of Natus Medical Inc, the total compensation of Austin Noll at Natus Medical Inc is $1,035,620. There are 2 executives at Natus Medical Inc getting paid more, with Jonathan Kennedy having the highest compensation of $3,335,550.
How old is Austin Noll?
Austin Noll is 53, he's been the Executive Vice President and Chief Commercial Officer of Natus Medical Inc since 2019. There are 16 older and 1 younger executives at Natus Medical Inc. The oldest executive at Natus Medical Inc is Kenneth Ludlum, 66, who is the Independent Director.
What's Austin Noll's mailing address?
Austin's mailing address filed with the SEC is NATUS MEDICAL INCORPORATED, 3150 PLEASANT VIEW ROAD, MIDDLETON, WI, 53562.
Insiders trading at Natus Medical Inc
Over the last 5 years, insiders at Natus Medical Inc have traded over $3,793,396 worth of Natus Medical Inc stock. The most active insiders traders include Dong Chune Christopher Chung, Joshua Levine und Jonathan Kennedy. On average, Natus Medical Inc executives and independent directors trade stock every 70 days with the average trade being worth of $543,972. The most recent stock trade was executed by Dong Chune Christopher Chung on 9 December 2021, trading 11,787 units of NTUS stock currently worth $243,755.
What does Natus Medical Inc do?
Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
What does Natus Medical Inc's logo look like?
Natus Medical Inc executives and stock owners
Natus Medical Inc executives and other stock owners filed with the SEC include:
-
Jonathan Kennedy,
President, Chief Executive Officer, Director -
B. Drew Davies,
Chief Financial Officer, Executive Vice President -
Austin Noll,
Executive Vice President and Chief Commercial Officer -
D. Christopher Chung,
Vice President - Quality, Regulatory Affairs and Chief Medical Officer -
Benjamin Drew Davies,
Exec. VP & CFO -
Austin F. Noll III,
Exec. VP & Chief Commercial Officer -
Dr. D. Christopher Chung M.D.,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Dr. D. Christopher Chung,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Barbara Paul,
Independent Chairman of the Board -
Kenneth Ludlum,
Independent Director -
Lisa Heine,
Independent Director -
Joshua Levine,
Independent Director -
Thomas Joseph Sullivan,
Pres, CEO & Director -
Alice Schroeder,
Independent Director -
Thomas Sullivan,
Independent Director -
Ilan Daskal,
Independent Director -
William Hill,
General Counsel -
Sean Langan,
Vice President of Global Operations -
Lisa Paul,
Vice President and Chief People Officer -
Douglas Balog,
VP, Gen. Counsel & Sec. -
Lisa Paul,
Chief People Officer & VP -
Ivan Pandiyan,
VP of Global R&D -
Seán Langan,
VP Global Operations -
Eric Guerin,
Director -
Bryant M Moore,
Director